These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20844506)

  • 21. Cloned animals deemed safe to eat, but labeling issues loom.
    Fox JL
    Nat Biotechnol; 2008 Mar; 26(3):249-50. PubMed ID: 18327214
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetically modified salmon vying for a spot at the dinner table.
    McCarthy A
    Chem Biol; 2011 Jan; 18(1):1-2. PubMed ID: 21276930
    [No Abstract]   [Full Text] [Related]  

  • 23. US academia held accountable for GM products.
    Powell K
    Nat Biotechnol; 2003 Jul; 21(7):720-1. PubMed ID: 12833077
    [No Abstract]   [Full Text] [Related]  

  • 24. Don't rely on Uncle Sam.
    Nature; 2005 Apr; 434(7035):807. PubMed ID: 15829921
    [No Abstract]   [Full Text] [Related]  

  • 25. Improving the FDA's advisory committee process.
    Brass EP; Hiatt WR
    J Clin Pharmacol; 2012 Aug; 52(8):1277-83. PubMed ID: 21908879
    [No Abstract]   [Full Text] [Related]  

  • 26. Two views of the emperor's new clones.
    Schubert D
    Nat Biotechnol; 2007 Mar; 25(3):282-3. PubMed ID: 17344873
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA transgenic animal guidance finally surfaces.
    Fox JL
    Nat Biotechnol; 2008 Nov; 26(11):1205-7. PubMed ID: 18997745
    [No Abstract]   [Full Text] [Related]  

  • 28. A breed apart.
    Nature; 2006 Nov; 444(7116):137. PubMed ID: 17093424
    [No Abstract]   [Full Text] [Related]  

  • 29. Advisory committees" critical to the FDA's product review process.
    Rados C
    FDA Consum; 2004; 38(1):17-9. PubMed ID: 15032199
    [No Abstract]   [Full Text] [Related]  

  • 30. Bioengineered pigs go to market.
    Kuehn BM
    J Am Vet Med Assoc; 2003 Apr; 222(7):926. PubMed ID: 12685776
    [No Abstract]   [Full Text] [Related]  

  • 31. Fishy business.
    Nature; 2014 Jul; 511(7511):507. PubMed ID: 25079517
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccines in the pipeline: the path from development to use in the United States.
    Pickering LK; Walton LR
    Pediatr Ann; 2013 Aug; 42(8):146-52. PubMed ID: 23910027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically engineered Salmon on the FDA's table.
    Taylor DA
    Environ Health Perspect; 2010 Sep; 118(9):a384-5. PubMed ID: 20810340
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of new regulations for pediatric labeling by the Food and Drug Administration.
    Buck ML
    Pediatr Nurs; 2000; 26(1):95-6. PubMed ID: 12026326
    [No Abstract]   [Full Text] [Related]  

  • 35. US calls for early data on transgenic crop safety.
    Check E
    Nature; 2002 Aug; 418(6898):571. PubMed ID: 12167819
    [No Abstract]   [Full Text] [Related]  

  • 36. Transparency at the Food and Drug Administration.
    Asamoah AK; Sharfstein JM
    N Engl J Med; 2010 Jun; 362(25):2341-3. PubMed ID: 20484392
    [No Abstract]   [Full Text] [Related]  

  • 37. Women's health and the FDA.
    Wood SF
    N Engl J Med; 2005 Oct; 353(16):1650-1. PubMed ID: 16236734
    [No Abstract]   [Full Text] [Related]  

  • 38. US animal biotech regulations "may not be adequate".
    Fox JL
    Nat Biotechnol; 2002 Oct; 20(10):959. PubMed ID: 12355099
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene-edited animal creators look beyond US market.
    Ledford H
    Nature; 2019 Feb; 566(7745):433-434. PubMed ID: 30809056
    [No Abstract]   [Full Text] [Related]  

  • 40. Food and drug administration expanded access to treatment: implications for oncology patients.
    Freedman RS; Markman M
    Cancer; 2007 Jun; 109(11):2157-60. PubMed ID: 17450587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.